115
Participants
Start Date
August 17, 2018
Primary Completion Date
December 31, 2023
Study Completion Date
June 30, 2024
Lipoic acid
1200 mg taken by mouth daily for two years starting on day one of the study and ending on the last day of study participation.
Placebo
The placebo comparator will be taken by mouth daily for two years starting on day one of the study and ending on the last day of study participation
Washington DC VA Medical Center, Washington, DC, Washington D.C.
University of Alabama at Birmingham, Birmingham
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
University of Colorado, Aurora
University of Utah, Salt Lake City
VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Swedish Medical Center, Seattle
VA Portland Health Care System, Portland, OR, Portland
University of Vermont, Burlington
Ottawa Hospital Research Institute, Ottawa
VA Office of Research and Development
FED